Nov 12 (Reuters) - Novavax (NVAX.O), opens new tab cut its annual ... the news and media division of Thomson Reuters, is the ...

A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including World <a target=_blank ...

The U.S. Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID-influenza and its standalone flu vaccines, the company said on Monday.

The selection of vaccine sceptic Robert F Kennedy Jr by US President-elect Donald Trump to head the Department of Health and ...

Novavax is already poised to benefit from a separate combined Covid-flu vaccine via a deal with Sanofi announed earlier this year. Under the $1.4 billion co-licensing agreement, announced in May, ...

Novavax, Inc. ( NASDAQ: NVAX) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ET ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved an adapted version of the Nuvaxovid COVID-19 vaccine that targets the ...

Novavax Inc. closed $15.40 short of its 52-week high ($23.86), which the company achieved on June 6th. Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated ...

In the run-up to the US election and in the days since, a dormant market narrative awoke. Small-caps, which had a lively but shortlived rally back in July, have surged since mid-October, outperforming ...

(Reuters) -U.S. stock index futures fell on Friday after Federal Reserve Chair Jerome Powell said there was no need to rush ...

U.S. stock index futures fell on Friday after Federal Reserve Chair Jerome Powell said there was no need to reduce interest ...

President-elect Donald Trump has selected Robert F. Kennedy Jr., a prominent vaccine skeptic, to lead the Department of ...